E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Cell Death and Differentiation Year : 2008

E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.

Abstract

The transcription factor E2F1 has a key function during S phase progression and apoptosis. It has been well-demonstrated that the apoptotic function of E2F1 involves its ability to transactivate pro-apoptotic target genes. Alternative splicing of pre-mRNAs also has an important function in the regulation of apoptosis. In this study, we identify the splicing factor SC35, a member of the Ser-Rich Arg (SR) proteins family, as a new transcriptional target of E2F1. We demonstrate that E2F1 requires SC35 to switch the alternative splicing profile of various apoptotic genes such as c-flip, caspases-8 and -9 and Bcl-x, towards the expression of pro-apoptotic splice variants. Finally, we provide evidence that E2F1 upregulates SC35 in response to DNA-damaging agents and show that SC35 is required for apoptosis in response to these drugs. Taken together, these results demonstrate that E2F1 controls pre-mRNA processing events to induce apoptosis and identify the SC35 SR protein as a key direct E2F1-target in this setting.

Dates and versions

inserm-00360967 , version 1 (17-02-2009)

Identifiers

Cite

Galina Merdzhanova, Valérie Edmond, Sandrine de Seranno, Arnaud van den Broeck, Laurent Corcos, et al.. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.. Cell Death and Differentiation, 2008, 15 (12), pp.1815-23. ⟨10.1038/cdd.2008.135⟩. ⟨inserm-00360967⟩
94 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More